These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6765542)

  • 21. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.
    Rosenstock J; Park G; Zimmerman J;
    Diabetes Care; 2000 Aug; 23(8):1137-42. PubMed ID: 10937511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the pharmacokinetics and metabolic effects of human regular and NPH insulin mixtures.
    Davis SN; Thompson CJ; Brown MD; Home PD; Alberti KG
    Diabetes Res Clin Pract; 1991 Aug; 13(1-2):107-17. PubMed ID: 1773708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of the effects of protamine-bound NPH porcine insulin and NPH human insulin in type 1 and 2 diabetes].
    Renner R; Vocke K; Hepp KD
    Dtsch Med Wochenschr; 1986 Aug; 111(35):1316-20. PubMed ID: 3743441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of basal hepatic glucose production and fasting hyperglycemia of type I diabetic patients treated with human recombinant ultralente insulin.
    Riccio A; Avogaro A; Valerio A; Zappella A; Tiengo A; Del Prato S
    Diabetes Care; 1994 Jun; 17(6):535-40. PubMed ID: 8082521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing effect of mixing insulins by glucose-clamp technique in subjects with diabetes mellitus.
    Colagiuri S; Villalobos S
    Diabetes Care; 1986; 9(6):579-86. PubMed ID: 3542452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.
    Koivisto VA; Tuominen JA; Ebeling P
    Diabetes Care; 1999 Mar; 22(3):459-62. PubMed ID: 10097929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Need stable diabetics mix their insulins?
    Roland JM
    Diabet Med; 1984 May; 1(1):51-3. PubMed ID: 6242778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).
    Danne T; Philotheou A; Goldman D; Guo X; Ping L; Cali A; Johnston P
    Pediatr Diabetes; 2013 Dec; 14(8):593-601. PubMed ID: 23730996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind crossover trial comparing human insulin (recombinant DNA) with animal insulins in the treatment of previously insulin-treated diabetic patients.
    Clark AJ; Wiles PG; Leiper JM; Knight G; Adeniyl-Jones RO; Watkins PJ; Ward JD; MacCuish AC; Keen H; Jones RH
    Diabetes Care; 1982; 5 Suppl 2():129-34. PubMed ID: 6765523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bovine and human NPH insulins as T cell immunogens.
    Gregory R; Tattersall RB
    Diabetes Res Clin Pract; 1993 May; 20(2):139-46. PubMed ID: 8375267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-action characteristics of regular and NPH insulin in insulin-treated diabetics.
    Roy B; Chou MC; Field JB
    J Clin Endocrinol Metab; 1980 Mar; 50(3):475-9. PubMed ID: 6987253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review.
    Frier BM; Russell-Jones D; Heise T
    Diabetes Obes Metab; 2013 Nov; 15(11):978-86. PubMed ID: 23551900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of fixed-ratio versus variable-ratio regular and NPH semisynthetic human insulin in insulin-requiring diabetic patients.
    Khachadurian AK; Davidson JA; Braunstein S; Redmond G; Greenfield M; Lauritano AA; Haycock P
    Clin Ther; 1989; 11(4):485-94. PubMed ID: 2673516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes.
    Linn T; Fischer B; Soydan N; Eckhard M; Ehl J; Kunz C; Bretzel RG
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3839-46. PubMed ID: 18611975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection.
    Lucidi P; Porcellati F; Marinelli Andreoli A; Carriero I; Candeloro P; Cioli P; Bolli GB; Fanelli CG
    Diabetes Care; 2015 Dec; 38(12):2204-10. PubMed ID: 26358287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
    Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
    Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of porcine and human isophane (NPH) insulins in normal subjects.
    Owens DR; Jones IR; Birtwell AJ; Burge CT; Luzio S; Davies CJ; Heyburn P; Heding LG
    Diabetologia; 1984 Apr; 26(4):261-5. PubMed ID: 6376233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Insulin glargine improves fasting blood glucose levels in prepubertal children with unsatisfactorily controlled type 1 diabetes].
    Mianowska B; Szadkowska A; Czerniawska E; Pietrzak I; Bodalski J
    Pediatr Endocrinol Diabetes Metab; 2007; 13(4):189-93. PubMed ID: 18042313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.
    Annuzzi G; Del Prato S; Arcari R; Bellomo Damato A; Benzi L; Bruttomesso D; Calderini MC; Coscelli C; Fedele D; Galluzzo A; Giordano M; Giorgino R; Lapolla A; Orsini P; Pagano G; Santoro D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):168-75. PubMed ID: 11590992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.
    Riddle MC; Hart JS; Bouma DJ; Phillipson BE; Youker G
    Diabetes Care; 1989 Oct; 12(9):623-9. PubMed ID: 2507265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.